Product Benefits:

• Effective Seizure Control: Primarily used to treat partial-onset seizures (fits) in patients with epilepsy, helping to reduce the frequency of attacks.

• High Selectivity: Brivaracetam has a high affinity for the synaptic vesicle protein 2A (SV2A) in the brain, which is key to its anticonvulsant activity.

• Flexible Dosage: Can be used as a standalone monotherapy or as an adjunctive therapy alongside other anti-epileptic medications.

• Rapid Absorption: Reaches peak plasma concentration quickly, ensuring the medication starts working shortly after ingestion.

• Broad Age Group: Indicated for use in adults and children (usually 4 years and older), making it a versatile choice for family members.

• No Titration Required: Unlike some other anti-epileptics, Briva often does not require a long period of gradual dose increasing to reach an effective level.